Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.53 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.53 |
| ▸ | TDP2 | O95551 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | BMP1 | P13497 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6641428 | 0.92 | CTRB1 (0.52) | ELANECTRB1TDP2NPC1RAB9A | |
| SCHEMBL6639603 | 0.89 | CTRB1 (0.50) | ELANECTRB1TDP2RAB9ATSHR | |
| SCHEMBL6401408 | 0.88 | CTRB1 (0.54) | ELANECTRB1TDP2TSHREGFR | |
| SCHEMBL6641379 | 0.88 | CTRB1 (0.53) | ELANECTRB1TSHRCYP1A2 | |
| SCHEMBL6639608 | 0.87 | CTRB1 (0.53) | ELANECTRB1TDP2EGFRERBB2 | |
| SCHEMBL6637009 | 0.86 | CTRB1 (0.52) | ELANECTRB1TDP2NPC1RAB9A | |
| SCHEMBL6635009 | 0.86 | ELANE (0.49) | ELANECTRB1TDP2NPC1RAB9A | |
| SCHEMBL6637376 | 0.85 | CTRB1 (0.49) | ELANECTRB1TDP2NPC1RAB9A | |
| SCHEMBL6639306 | 0.85 | ELANE (0.60) | ELANECTRB1TDP2MMP2MMP13 | |
| SCHEMBL6637258 | 0.83 | CTRB1 (0.51) | ELANECTRB1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |